Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Oct 21.
Published in final edited form as: J Am Geriatr Soc. 2013 Jan 15;61(2):237–242. doi: 10.1111/jgs.12077

Mid-life physical activity preserves lower extremity function in older adults: Age Gene/Environment Susceptibility (AGES) - Reykjavik Study

Milan Chang *, Jane S Saczynski , Jon Snaedal *,, Sigurbjorn Bjornsson *, Bjorn Einarsson *, Melissa Garcia #, Thor Aspelund §,, Kristine Siggeirsdottir §, Vilmundur Gudnason *,§, Lenore J Launer #, Tamara B Harris #, Palmi V Jonsson *,
PMCID: PMC4205047  NIHMSID: NIHMS416118  PMID: 23320618

Abstract

OBJECTIVES

To examine the long-term association between mid-life physical activity (PA) and lower extremity function (LEF) in late-life.

DESIGN

A longitudinal study with an average of 25 years of follow up.

PARTICIPANTS

A large community-based population of 4753 men and women (mean age 76±6 yrs) residing in Reykjavik, Iceland.

MEASUREMENTS

On the basis of weekly hours of regular PA reported at the mid-life examination, participants were classified as “Active” and “Inactive”. Measures of LEF in late-life included gait speed from 6m walk (meter per second, m/s), Timed Up and Go (TUG, second), and Knee Extension (KE) strength (kg) tests. Linear regression analysis was used to examine the association.

RESULTS

Participants who were active in mid-life had significantly better LEF (faster gait speed,, β = 0.05, p ≤ 0.001; faster TUG time, β = −0.53, p ≤ 0.001; stronger KE strength, β = 1.3, p ≤ 0.001) in late-life compared with those who were not active in mid-life, after adjusting for socio-demographic and cardiovascular risk factors. After adjustment for cognitive function in late life (speed of processing, memory, and executive function), participants who were active in mid-life still had significantly faster gait speed (β = 0.04, p ≤ 0.001), faster TUG time (β = −0.34, p ≤ 0.001), and greater KE strength (β = 0.87, p ≤ 0.001) in old age compared with those who were not active in mid-life.

CONCLUSION

Regular PA reported in mid-life is associated with better performance of LEF in later life, even after controlling for late life cognitive function.

Keywords: mid-life physical activity, mobility, aging, cognitive function, lower extremity function

INTRODUCTION

Mobility is critical for maintaining physical independence of older people, and regular PA participation in early life is associated with mobility in old age 1, 2. Lower extremity function (LEF) is the main indicator of mobility which is often used as a clinical screening tool 3, 4. LEF is generally assessed by measuring walking capacity 5 and leg strength 6, 7. Mobility is also strongly related to cognitive ability 8 which is associated with both LEF 8-10 and PA participation in older population 11. Having both low levels of PA and cognitive function are associated with reduced mobility in old age 12. However, it is unclear whether the effects of midlife PA on LEF are independent of the effects on cognition. The long-term association between mid-life PA and late-life LEF with adequate control for more details of cognitive performance would extend the current knowledge of the association.

The aim of the current study was to examine the long-term association between mid-life PA and LEF in late-life among older people adjusting for confounders from mid-life and late-life. The AGES-Reykjavik Study assessed various specific domains of cognitive function at the late-life examination on average 25 years later, which allows us to evaluate if this relationship is independent of cognitive function with full adjustment for multiple mid-life and late-life confounders. In a secondary analysis, we further investigate the association in a population free of dementia adjusting for confounders from mid-life and late-life, as well as measures of various domains of cognitive function.

METHODS

Study Population

Age Gene/Environment Susceptibility (AGES) - Reykjavik Study

The Reykjavik Study (RS) was initiated in 1967 by the Icelandic Heart Association to study cardiovascular disease and associated risk factors. The cohort included men and women born in 1907–1935, living in Reykjavik. The details of RS have been published previously 13. Surviving members of the RS cohort were re-invited in 2002 to participate in the AGES-Reykjavik Study. Re-examination included a structured survey instrument, cognitive testing, brain MRI, and physical performance tests. All participants signed an informed consent. Details on the AGES-Reykjavik Study have been described elsewhere 14.

Mid-life Leisure Time Physical Activity

At the mid-life RS examination, interviewers asked participants two questions about leisure time PA, 1) if they regularly participated in sports or exercise and 2), how many hours per week they participated in sports or exercise separately in the winter and summer (1=none, 2=5 hours or less, and 3=more than 5 hours). Two categories of mid-life PA were defined: 1) Active = reported any PA hours during summer or winter, and 2) Inactive = reported no PA hours in both winter and summer.

LEF performance test

LEF was assessed in late-life as part of the AGES-Reykjavik Study using the 6 meter walk test 15, the timed up and go test 16, and knee extension strength 3, 17, similar to the assessments of LEF that have been used in other epidemiological and clinical studies 5. Each test is described below.

Gait speed (6 meter walk)

Gait speed was assessed in meters in second from a 6 meter walking test at usual speed 6. This test is reliable when performed in a standardized fashion, and well tolerated by older people 15. The average time of two trials was used in the analysis.

Timed Up and Go (TUG)

The Timed Up and Go 16 measures the time taken to stand up from a sitting position, walk 3 meters, turn around, walk back to the chair, and sit down. It is a useful screening test for balance problems among older people 18 and is used as a predictor of decline in activities of daily living (ADL) 16. When taking the test, participants had their own footwear on and a cane or walker was allowed if necessary. Those who could not rise from the chair (height = 45.5 cm) by themselves or walk were excluded from the test. The time of the first complete trial was used in the analysis.

Knee Extension Strength (KES)

Lower extremity strength was measured as maximum isometric strength of knee extension using an adjustable and computerized dynamometer on a fixed chair (Good Strength, Metitur, Palokka. Finland) 19. KES was measured at a fixed knee angle of 60 degrees from full extension toward flexion during which the ankle was fastened to a strain-gauge transducer by a belt. The right leg was measured in two trials of knee extensions, each lasting 4 seconds, with a 30 second rest in between. Participants who had surgery on their leg or hand, or had any ischemic heart conditions in the past 2 months were excluded from the tests. Highest maximum force was used in the analysis.

Cognitive Function and Dementia

All participants were administered a battery of cognitive tests 20 once at the baseline visit. Composite scores were constructed for speed of processing (SP), memory (MEM), and executive function (EF) based on a theoretical grouping of tests, similar to other population-based studies 20. Details have been described in a previous study 21. A consensus diagnosis of dementia was made according to international guidelines, Diagnostic and Statistical Manual of Mental Disorder, Fourth Edition (DSM-IV) 22, by a geriatrician, neurologist, neuropsychologist and a neuroradiologist.

Covariates

Several demographic and health factors were controlled for in subsequent analyses. Measures obtained from the mid-life RS examination included education, blood pressure (BP, mmHG), height (cm), weight (kg), serum cholesterol (mmol/L), and smoking status (never/previous/current). Education was categorized into 4 levels (elementary school, high school, undergraduate, more than undergraduate education). BP was measured in a semi-recumbent position using mercury sphygmomanometer and a cuff of appropriate size on the right arm after subjects had rested for several minutes. Body mass index (BMI) was calculated with weight in kilogram divided by height in squared meters. Serum cholesterol level was measured from a blood sample drawn at the in-person examination in a fasting/thirsting state.

Variables collected at the late-life AGES-Reykjavik Study were also included in the analysis as covariates. Diabetes was defined as self-reported doctor’s diagnosis, late-life medication use, or fasting glucose level ≥7.0 mmol/L. Coronary events included both those identified in an on-going surveillance system or self-reported history of myocardial infarction, coronary bypass surgery, heart bypass surgery, angioplasty or other coronary artery diseases. Self-reported doctor’s diagnosis of stroke was assessed via questionnaire. Global cognitive function was examined using Mini-Mental State Examination (MMSE). High levels of depressive symptoms was classified as a score of ≥ 6 on the 15-item Geriatric Depression Scale (GDS) 23.

Analytical Sample

Of the total study cohort (n=5764), 797 subjects (317 men and 480 women) were excluded because of missing data on the LEF tests, and 214 (110 men and 104 women) subjects with diagnosed dementia were excluded because dementia is significantly associated with low LEF 9, 24. The final study population was 4753 participants (2011 men and 2742 women). Participants included in the analysis were significantly younger (mean late-life age 76.5 ± 5.5 years), and generally healthier (data not shown) compared with excluded population (n = 1011, mean age 80.5 ± 6.4 years). From the final study cohort, 4359 subjects with complete cognitive data were selected for the secondary analysis to examine the association adjusting for various aspects of cognitive function.

Statistical Analysis

We used descriptive statistics to examine sociodemographic and health characteristics according to the mid-life PA category. General linear regression models were used for continuous variables, and chi-square (χ 2) tests were used for categorical variables to compare subject characteristics. The difference in performance of gait speed, TUG, and KE strength tests of LEF by the mid-life PA level was examined by linear regression analysis, adjusting for confounders. The first model was adjusted for age, sex, and education. A second model was further adjusted for mid-life covariates (cholesterol level, systolic BP, smoking, and BMI), and a third model was further adjusted for late-life covariates (diabetes, history of coronary events, high depressive symptoms, and self-reported strokes). The final (4th) model was additionally adjusted for MMSE score.

Secondary analyses were conducted for the sub-population of 4359 people who had complete cognitive subscale data. All models from original analyses were repeated in the secondary analyses, but the final model was adjusted for the cognitive subscales instead of MMSE. Statistical analyses were performed using the STATA software, version 10 (Statacorp, Texas, USA).

RESULTS

Compared with the inactive group, the active group had slightly younger age, a shorter average follow-up time, higher education level, higher MMSE scores, and were less likely to have ever smoked (all p’s <0.05, Table 1).

Table 1. Demographic and Health Characteristics by Level of Mid-life Physical Activity (n = 4753).

Mid-life PA (n=4753)
Inactive Group
(n=3275)
Active Group
(n=1478)

Variable Mean SD Mean SD P (age adj.)
Follow-up time, mean (± SD), y 25.5 (4.0) 24.4 (4.5) <.001
Female no. (%) 1912 (58.4 ) 830 (56.2) .138
Elementary education, primary only, no. (%) 837 (25.6) 221 (15.0) <.001
Mid-life Examination
   Age, mean (± SD), y 50.9 (6.5) 51.7 (7.2)
   Body mass index, mean (± SD) 25.2 (3.6) 25.1 (3.1) .385
   Systolic blood pressure, mean (± SD), mmHg 131.0 (19.0) 130.2 (18.2) .269
   Cholesterol, mean (± SD), mmol/l 6.4 (1.1) 6.3 (1.1) .748
   Midlife never smoked, no. (%) 1281 (39.2) 619 (41.9) .053
Current Examination
   Age, mean (± SD), y 76.4 (5.5) 76.0 (5.4)
   Body mass index, mean (± SD) 27.2 (4.5) 26.9 (4.2) .063
   Systolic blood pressure, mean (± SD), mmHg 142.6 (20.2) 141.7 (20.0) .224
   Cholesterol, mean (± SD), mmol/L 5.7 (1.2) 5.6 (1.2) .111
   MMSE, mean (± SD) 26.7 (2.7) 27.2 (2.6) <.001
   Diabetes, no. (%) 399 (12.2) 163 (11.0) .251
   Coronary event, no. (%) 469 (14.3) 217 (14.7) .832
   Self reported stroke, no. (%) 186 (5.7) 89 (6.0) .731
   High depressive symptoms#, no. (%) 219 (6.7) 75 (5.1) .083
   Never smoked, no. (%) 1310 (40.9) 660 (45.6) .002
   PA hours/week in the past 12 month, mean (± SD) 1.0 (2.0) 1.8 (2.5) <.001
Lower Extremity Function
   Gait speed, mean (± SD), meter/sec 0.9 (0.2) 1.0 (0.2) <.001
   Timed up and go, mean (± SD), sec 12.5 (3.3) 11.8 (3.0) <.001
   Knee extension, mean (± SD), kg 32.0 (11.6) 34.1 (12.2) <.001
#

15-item Geriatric Depression Scale score ≥6

Abbreviations: PA = physical activity, MMSE = mini mental state examination, SD = standard deviation, no = number, sec = second

After adjusting for age, gender, and education (Model 1, Table 2), the active group had 0.055 m/s faster gait speed, completed TUG test 0.6 second faster, and had 1.5 kg greater KES compared the inactive group (all p’s < 0.001). After adjusting for risk factors from both mid-life (model 2) and current life (model 3), the results remained similar with model 1. With additional adjustment for MMSE in model 4, all LEF tests were still significantly associated with mid-life PA level (Table 2) with attenuations up to 11%. After the full adjustment, compared with the inactive group, the active group had 0.049 m/s faster gait speed (95% Confidence Interval (CI): 0.038, 0.059, P < 0.001), completed TUG test 0.53 seconds faster (CI: −0.71 ~ −0.36, P < 0.001), and had 1.34 kg greater KES (CI: 0.83 ~ 1.86, P < 0.001).

Table 2.

Association of Lower Extremity Function and Midlife PA Among Dementia Free Population

Adjusted mean differences of lower extremity function scores by mid-life PA levels
Population (n=4753) Active Group (n=1478) versus Inactive Group (n= 3275)

Lower Extremity Function β coefficient (95% Confidence Interval ) P-value
Model 1 0.055* (0.044 ~ 0.066) <.0001
Gait Speed Model 2 0.053* (0.042 ~ 0.064) <.0001
Model 3 0.053* (0.042 ~ 0.064) <.0001
Model 4 0.049* (0.038 ~ 0.059) <.0001
Model 1 −0.62* (−0.80 ~ −0.44) <.0001
Timed Up and Go Model 2 −0.59* (−0.77 ~ −0.41) <.0001
Model 3 −0.59* (−0.77 ~ −0.41) <.0001
Model 4 −0.53* (−0.71 ~ −0.36) <.0001
Model 1 1.50* (0.98 ~ 2.02) <.0001
Knee Extension Model 2 1.51* (0.99 ~ 2.03) <.0001
Model 3 1.50* (0.98 ~ 2.02) <.0001
Model 4 1.34* (0.83 ~ 1.86) <.0001

Model 1 = adjusted for age, sex and education

Model 2 = + midlife covariates: BMI, systolic blood pressure, cholesterol, and smoking

Model 3 = + late-life covariates: diabetes, coronary event, high depressive symptoms, smoking, and self reported stroke

Model 4 = + MMSE score

Abbreviations: PA, physical activity; MMSE, mini mental state examination

The secondary analysis was performed in sub-population with complete domain specific cognitive data. The results from the first three models in the secondary analysis were similar with the original analysis. In the final model (model 4, Table 3), after adjusting for detailed cognitive function of SP, MEM and EF, the coefficients of three LEF performance tests were attenuated by up to 41%, but remained significant. Compared with the inactive group, the active group had 0.037 m/s higher gait speed (95% CI: 0.026, 0.048, P < 0.001), completed TUG test 0.34 seconds faster (CI: −0.52 ~ −0.16, P < 0.001), and had 0.87 kg greater KES (CI: 0.34 ~ 1.42, P < 0.001).

Table 3.

Secondary Analysis For an Association of Lower Extremity Function and Mid-life PA among Population with Details of Cognitive Function

Adjusted mean differences of lower extremity function by mid-life PA levels
Population (n=4359) Active (n=1364) versus Not Active (n=2995)

Lower Extremity Function β coefficient (95% Confidence Interval ) P-value
Model 1 0.054* (0.042 ~ 0.065) <.0001
Gait Speed Model 2 0.052* (0.041 ~ 0.063) <.0001
Model 3 0.052* (0.041 ~ 0.063) <.0001
Model 4 0.037* (0.026 ~ 0.048) <.0001
Model 1 −0.59* (−0.78 ~ −0.40) <.0001
Timed Up and Go Model 2 −0.57* (−0.76 ~ −0.39) <.0001
Model 3 −0.58* (−0.76 ~ −0.39) <.0001
Model 4 −0.34* (−0.52 ~ −0.16) .006
Knee Extension Model 1 1.44* (0.89 ~ 1.98) <.0001
Model 2 1.43* (0.89 ~ 1.98) <.0001
Model 3 1.43* (0.89 ~ 1.98) <.0001
Model 4 0.87# (0.34 ~ 1.42) .001

Model 1 = adjusted for age, sex and education

Model 2 = + midlife covariates: BMI, systolic blood pressure, cholesterol, and smoking

Model 3 = + late-life covariates: diabetes, coronary event, high depressive symptoms, smoking, and self reported stroke

Model 4 = + cognitive composite scores of speed of processing, memory, and executive function

Abbreviations: PA, physical activity

DISCUSSION

Participants who were active at mid-life had significantly better LEF indicated by faster gait speed, faster time to complete timed up and go test, and stronger knee extension strength compared with those who were inactive at mid-life. The association remained strong even after adjusting for various confounders from mid-life and late-life including cognitive function. Our longitudinal data are unique with regard to assessment of the association between an unbiased report of mid-life PA and LEF as ascertained a mean of twenty-five years later. Further, the association was controlled with subscales of cognitive function in a secondary analysis. The current study contributes strong evidence of a long-term association between PA and LEF with insights into how this association might be affected by the development of cognitive difficulty.

Our study has several strengths. First, data was from a large and well-described population-based cohort initially representative of the population of an urban center, and our study follow-up time was an average interval of 26-years. Second, weekly hours of PA were recorded at the time of mid-life examination. Third, the late-life examination included objective LEF performance tests. Finally, we investigated the effect of various domains of cognitive function on the association between mid-life PA and late-life LEF in a secondary analysis. Our study also has some limitations. Although we used a standardized PA questionnaire, it only included limited number of items related to sports and exercise, and did not include items for housework and related activities. Additionally, the study was limited by the lack of LEF performance data at mid-life, and also the study population could only include those who were still alive when the AGES-Reykjavik Study was initiated.

Evidence suggests that people who participated in a regular exercise program improved walking capacity compared with sedentary people 1, 25, 26. The performance of LEF (Gait, TUG, and KES) measured in our study represents mobility, which is an important element of independence among older adults. Although the magnitude was small, all LEF performance tests were significantly associated with mid-life PA level where the size of the effects in the active group compared with the inactive group were equivalent to 4.7, 3.5, and 2.6 years of age in gait speed, TUG, and, KES respectively (original analysis). That is, an active person had a gait speed comparable to, on average, someone 4.7 years younger than an inactive person. Our results are in agreement with previous reports about the effect of cognitive function on LEF 10, 27. However, the effect of adjusting for various aspects of cognitive function on the association between LEF and mid-life PA was much larger in the secondary analysis (up to 41 % attenuation) compared with the effect shown after adjusting for MMSE (up to 11 % attenuation). It suggests that the effect of cognitive function on LEF could be much stronger than is previously reported. When we investigated the effect of each cognitive domain (SP, MEM, and EF), SP had the strongest effect on the association in all three LEF performances (data not shown). A previous study using the same cohort reported a similar trend showing that SP had the strongest association with mid-life PA11.

Several mechanisms may contribute to our findings. The first possible hypothesis is that those who were active in mid-life were more likely to continue exercising during the interval years. In the AGES-Reykjavik Study, the active group reported a greater number of PA hours in all life span periods compared with the inactive group. The results after adjusting for current PA level in the final model were still highly significant (attenuation up to 27% in the original analysis and 34% in the secondary analysis) except knee strength in the secondary analysis (data not shown). Second, there is a direct physiological effect of regular PA on muscle and joint strength as well as on overall cardiovascular health 28. It is clear that people who engage in regular PA have greater muscle strength compared with sedentary people 28. Furthermore, there are other suggested benefits of regular PA such as improved aerobic capacity which helps in the prevention of cardiovascular disease 29, and preservation of cognitive function 11. Third, regular mid-life PA may have been influenced by self-efficacy, which may be associated with engagement in other social activities that involve PA in daily life 30. However, our study did not have information about social activities in mid-life, so we could not test this hypothesis.

CONCLUSION

Men and women who participated in regular PA during mid-life had better performance of LEF, a key function in maintenance of independence for older adults, 25 years later. Our data suggest that being active in mid-life is associated with better mobility in old age. Promoting regular PA among middle aged adults would help preserve mobility and delay disability in later life.

ACKNOWLEDGMENTS

This study was funded in part by the Intramural Research Program of the National Institutes of Health, the National Institute on Aging (N01-AG-12100), Icelandic Heart Association, Landspitali University Hospital, and the Icelandic Parliament. The study was approved by the National Bioethics Committee in Iceland (approval VSN-00-063) Data Protection Authority, and by the National Institute on Aging Intramural Institutional Review Board. Written informed consent was obtained from all participants.

Sponsor’s Role: None.

REFERENCES

  • 1.Patel KV, Coppin AK, Manini TM, et al. Midlife physical activity and mobility in older age: The InCHIANTI study. Am J Prev Med. 2006 Sep;31(3):217–224. doi: 10.1016/j.amepre.2006.05.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Visser M, Pluijm SM, Stel VS, et al. Physical activity as a determinant of change in mobility performance: the Longitudinal Aging Study Amsterdam. J Am Geriatr Soc. 2002 Nov;50(11):1774–1781. doi: 10.1046/j.1532-5415.2002.50504.x. [DOI] [PubMed] [Google Scholar]
  • 3.Rantanen T, Guralnik JM, Ferrucci L, et al. Coimpairments: strength and balance as predictors of severe walking disability. J Gerontol A Biol Sci Med Sci. 1999 Apr;54(4):M172–176. doi: 10.1093/gerona/54.4.m172. [DOI] [PubMed] [Google Scholar]
  • 4.Studenski S, Perera S, Wallace D, et al. Physical performance measures in the clinical setting. J Am Geriatr Soc. 2003 Mar;51(3):314–322. doi: 10.1046/j.1532-5415.2003.51104.x. [DOI] [PubMed] [Google Scholar]
  • 5.Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994 Mar;49(2):M85–94. doi: 10.1093/geronj/49.2.m85. [DOI] [PubMed] [Google Scholar]
  • 6.Guralnik JM, Ferrucci L, Simonsick EM, et al. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med. 1995 Mar 2;332(9):556–561. doi: 10.1056/NEJM199503023320902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Brach JS, Simonsick EM, Kritchevsky S, et al. The association between physical function and lifestyle activity and exercise in the health, aging and body composition study. J Am Geriatr Soc. 2004 Apr;52(4):502–509. doi: 10.1111/j.1532-5415.2004.52154.x. [DOI] [PubMed] [Google Scholar]
  • 8.Buchman AS, Boyle PA, Leurgans SE, et al. Cognitive function is associated with the development of mobility impairments in community-dwelling elders. Am J Geriatr Psychiatry. 2011 Jun;19(6):571–580. doi: 10.1097/JGP.0b013e3181ef7a2e. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Eggermont LH, Gavett BE, Volkers KM, et al. Lower-extremity function in cognitively healthy aging, mild cognitive impairment, and Alzheimer’s disease. Arch Phys Med Rehabil. 2010 Apr;91(4):584–588. doi: 10.1016/j.apmr.2009.11.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Atkinson HH, Rosano C, Simonsick EM, et al. Cognitive function, gait speed decline, and comorbidities: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci. 2007 Aug;62(8):844–850. doi: 10.1093/gerona/62.8.844. [DOI] [PubMed] [Google Scholar]
  • 11.Chang M, Jonsson PV, Snaedal J, et al. The Effect of Midlife Physical Activity on Cognitive Function Among Older Adults: AGES--Reykjavik Study. J Gerontol A Biol Sci Med Sci. 2010 Aug 30;65(12):1369–1374. doi: 10.1093/gerona/glq152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Eggermont LH, Milberg WP, Lipsitz LA, et al. Physical activity and executive function in aging: the MOBILIZE Boston Study. J Am Geriatr Soc. 2009 Oct;57(10):1750–1756. doi: 10.1111/j.1532-5415.2009.02441.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Sigurdsson E, Thorgeirsson G, Sigvaldason H, et al. Prevalence of coronary heart disease in Icelandic men 1968-1986. The Reykjavik Study. Eur Heart J. 1993 May;14(5):584–591. doi: 10.1093/eurheartj/14.5.584. [DOI] [PubMed] [Google Scholar]
  • 14.Harris TB, Launer LJ, Eiriksdottir G, et al. Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics. Am J Epidemiol. 2007 May 1;165(9):1076–1087. doi: 10.1093/aje/kwk115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Cesari M, Kritchevsky SB, Penninx BW, et al. Prognostic value of usual gait speed in well-functioning older people--results from the Health, Aging and Body Composition Study. J Am Geriatr Soc. 2005 Oct;53(10):1675–1680. doi: 10.1111/j.1532-5415.2005.53501.x. [DOI] [PubMed] [Google Scholar]
  • 16.Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991 Feb;39(2):142–148. doi: 10.1111/j.1532-5415.1991.tb01616.x. [DOI] [PubMed] [Google Scholar]
  • 17.Fiatarone MA, Evans WJ. The etiology and reversibility of muscle dysfunction in the aged. J Gerontol. 1993 Sep;:48. doi: 10.1093/geronj/48.special_issue.77. Spec No:77-83. [DOI] [PubMed] [Google Scholar]
  • 18.Newton RA. Balance screening of an inner city older adult population. Arch Phys Med Rehabil. 1997 Jun;78(6):587–591. doi: 10.1016/s0003-9993(97)90423-8. [DOI] [PubMed] [Google Scholar]
  • 19.Era P. Maximal isometric muscle strength and anthropometry in 75-year-old men and women in three Nordic localities. Scand j Med Sci Sports. 1994;4:26–31. [Google Scholar]
  • 20.Wilson RS, Mendes De Leon CF, Barnes LL, et al. Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA. 2002;287(6):742–748. doi: 10.1001/jama.287.6.742. [DOI] [PubMed] [Google Scholar]
  • 21.Saczynski JS, Jonsdottir MK, Garcia ME, et al. Cognitive impairment: an increasingly important complication of type 2 diabetes: the age, gene/environment susceptibility--Reykjavik study. Am J Epidemiol. 2008;168(10):1132–1139. doi: 10.1093/aje/kwn228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33. quiz 34-57. [PubMed] [Google Scholar]
  • 23.Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17(1):37–49. doi: 10.1016/0022-3956(82)90033-4. [DOI] [PubMed] [Google Scholar]
  • 24.Verghese J, Wang C, Lipton RB, et al. Quantitative gait dysfunction and risk of cognitive decline and dementia. J Neurol Neurosurg Psychiatry. 2007 Sep;78(9):929–935. doi: 10.1136/jnnp.2006.106914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Rantanen T, Guralnik JM, Sakari-Rantala R, et al. Disability, physical activity, and muscle strength in older women: the Women’s Health and Aging Study. Arch Phys Med Rehabil. 1999 Feb;80(2):130–135. doi: 10.1016/s0003-9993(99)90109-0. [DOI] [PubMed] [Google Scholar]
  • 26.Keysor JJ, Jette AM. Have we oversold the benefit of late-life exercise? J Gerontol A Biol Sci Med Sci. 2001 Jul;56(7):M412–423. doi: 10.1093/gerona/56.7.m412. [DOI] [PubMed] [Google Scholar]
  • 27.Coppin AK, Shumway-Cook A, Saczynski JS, et al. Association of executive function and performance of dual-task physical tests among older adults: analyses from the InChianti study. Age Ageing. 2006 Nov;35(6):619–624. doi: 10.1093/ageing/afl107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Rantanen T, Era P, Heikkinen E. Physical activity and the changes in maximal isometric strength in men and women from the age of 75 to 80 years. J Am Geriatr Soc. 1997 Dec;45(12):1439–1445. doi: 10.1111/j.1532-5415.1997.tb03193.x. [DOI] [PubMed] [Google Scholar]
  • 29.Wannamethee SG, Shaper AG, Walker M. Changes in physical activity, mortality, and incidence of coronary heart disease in older men. Lancet. 1998 May 30;351(9116):1603–1608. doi: 10.1016/S0140-6736(97)12355-8. [DOI] [PubMed] [Google Scholar]
  • 30.McAuley E, Jerome GJ, Elavsky S, et al. Predicting long-term maintenance of physical activity in older adults. Prev Med. 2003 Aug;37(2):110–118. doi: 10.1016/s0091-7435(03)00089-6. [DOI] [PubMed] [Google Scholar]

RESOURCES